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Abstract
Disruptions in axonal transport have been implicated in a wide range of neurodegenerative diseases. Cramping 1 (Cra1/+)
and Legs at odd angles (Loa/+) mice, with hypomorphic mutations in the dynein heavy chain 1 gene, which encodes the
ATPase of the retrograde motor protein dynein, were originally reported to exhibit late onset motor neuron disease.
Subsequent, conflicting reports suggested that sensory neuron disease without motor neuron loss underlies the
phenotypes of Cra1/+ and Loa/+ mice. Here, we present behavioral and anatomical analyses of Cra1/+ mice. We
demonstrate that Cra1/+ mice exhibit early onset, stable behavioral deficits, including abnormal hindlimb posturing and
decreased grip strength. These deficits do not progress through 24 months of age. No significant loss of primary motor
neurons or dorsal root ganglia sensory neurons was observed at ages where the mice exhibited clear symptomatology.
Instead, there is a decrease in complexity of neuromuscular junctions. These results indicate that disruption of dynein
function in Cra1/+ mice results in abnormal morphology of neuromuscular junctions. The time course of behavioral deficits,
as well as the nature of the morphological defects in neuromuscular junctions, suggests that disruption of dynein function
in Cra1/+ mice causes a developmental defect in synapse assembly or stabilization.
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Introduction
Rapid axonal transport is essential for neurons with long axons,
both for development and mature functioning. Without transport,
neurotransmitter vesicles cannot move to synapses, damaged
organelles in the axon cannot be replaced by healthy organelles,
and target-derived survival signals cannot reach the cell body.
Because of the importance of axonal transport, it is not surprising
that disruptions in this process have been implicated in a wide
range of neurodegenerative diseases, including motor and sensory
neuropathies, Alzheimer’s disease, Parkinson’s disease, and
Huntington’s disease [1–4]. Perhaps because of the long distance
between cell bodies and distal axons in these neurons (over 1 meter
in an adult human), sensory and motor neurons appear to be
particularly sensitive to disruptions in axonal transport.
Disruptions in retrograde transport have been implicated in
neurodegenerative disease in mice as well as in humans.
Disrupting the function of the retrograde motor dynein in motor
neurons by overexpression of dynamitin causes late-onset motor
neuron degeneration in mice [5,6]. A mutation in the p150
Glued
subunit of the dynactin complex has been discovered in a family
with a progressive autosomal dominant form of lower motor
neuron disease, and mice with mutations in p150
Glued develop
motor neuron disease [7,8,6].
In 2003, Fisher and colleagues reported two lines of mice with
late onset, progressive motor neuron disease, called Legs at odd
angles (Loa/+) and Cramping 1 (Cra1/+) [9]. Both Loa/+ and Cra1/+
mice have a missense mutation in the dynein heavy chain 1 gene [9].
Heterozygous mice from both lines were reported to show an age-
related, progressive motor neuron disease, with cramping of
hindlimbs, gait abnormalities, and eventual paralysis. While the
number of motor neurons was normal in Cra1/+ mice at three
months of age, a severe reduction in motor neuron number was
reported at 16 months of age in Cra1/+ mice and 18 months of age
in Loa/+ mice, consistent with the progressive symptoms. In vitro,
neurons from Loa/Loa embryos exhibited a defect in the fast
component of retrograde transport without other alterations in the
ubiquitous functions of dynein, such as nuclear motility and Golgi
complex morphology and positioning. Furthermore, purified
dynein from Loa/+ and Loa/Loa mice exhibited reduced
processivity, premature run termination and altered coordination
of motor domains. These defects together lead to impaired
retrograde axonal transport [10]. Thus, it was concluded that
neuron degeneration in these mice arises from specific disruptions
in rapid retrograde axonal transport [9,10].
In contrast, two recent studies provide evidence that the Loa/+ and
Cra1/+ mice exhibit a sensory neuropathy without motor neuron
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and neuromuscular junction analysis in aged (18–22 months) Loa/+
and Cra1/+ micealldemonstrate normal motor neuron numbers and
innervation of muscle [11,12]. Both lines of mice were reported to
exhibit an early-onset sensory neuropathy, with reduced numbers of
large caliber proprioceptive axons in the dorsal root and reduced
innervation of muscles spindles. These results are similar to the
phenotype reported for Sprawling (Swl/+) mice, another hypomor-
phic mutation in dynein heavy chain 1 that exhibits proprioceptive
deficits and loss of proprioceptive neurons [13].
In order to clarify the link between disruption in axonal transport
and neuronal functioning we undertook a detailed examination of the
behavioral and anatomic phenotype in Cra1/+ mice. Behavioral
analysis revealed an early onset, stable phenotype in Cra1/+ mice,
with hindlimb cramping and impaired grip strength. We find no
evidence of motor or sensory neuron loss in the Cra1/+ mice at
symptomatic ages. Strikingly however, neuromuscular junctions in
Cra1/+ mice are abnormal. While the number and size of these
synapticzones areunchanged,the complexityof the pretzel-likeNMJ
is significantly reduced in mutant animals. Furthermore, analysis of
muscle fibers provides evidence of continuous muscle degeneration
and regeneration. These results suggest that the primary pathology in
Cra1/+ animals may be an early onset, non-progressive synaptic
dysfunction that affects the neuromuscular junction.
Results
Cra1/+ Mice Show an Early Onset, Stable Phenotype of
Neuronal Dysfunction
Cra1/+ mice were originally reported to exhibit late onset,
progressive degeneration of motor neurons [9]. In order to
characterize disease progression in these mice, we undertook a
long-term analysis of Cra1/+ mice. We find that Cra1/+ mice show
reduced survival compared to wild-type (+/+) mice (Figure 1A).
The cause of death was not evident in the majority of cases. We
did not observe hindlimb paralysis, increased seizure activity, or
other signs of nervous system or motor neuron dysfunction in the
majority of animals that died prematurely. The original identifi-
cation of the Cra1/+ line of mice was a result of their unusual
‘‘cramping’’ posture of the hindlimbs when suspended by the tail.
We documented the emergence of this cramping posture in Cra1/
+ mice between the ages of 15 days old and 12 months old by
scoring animals as either 1 (no hindlimb abnormalities), 2
(cramping of hindlimbs), or 3 (paralysis of one or both hindlimbs).
Surprisingly, we find that Cra1/+ mice demonstrate pronounced
cramping posture as early as 15 days of age, the earliest time that
could be tested (Figure 1B).
In order to assess motor neuron function in a quantitative
fashion in Cra1/+ mice, we used a digital grip strength meter to
record the power used to resist an opposing force with either fore-
or hindlimbs. This behavioral test requires the mice to grip a wire
grid attached to a force gauge and maintain their grip while they
are pulled away from the grid, necessitating both proper gripping
with the fore- and hindfeet as well as pulling with the limb muscles.
Measurement of both fore- and hindlimb grip strength shows an
early onset, stable reduction in grip strength compared to +/+
animals (Figure 1C). Interestingly, Cra1/+ mice show stable grip
strength measurements over time, indicating that the dysfunction
in grip strength does not progress with age.
Cra1/+ Mice Do Not Show Evidence of Motor or Sensory
Neuron Loss at Symptomatic Ages
To investigate motor neuron degeneration in Cra1/+ mice, we
examined motor neuron cell bodies in the spinal cord for evidence
of pathology. Choline acetyltransferase (ChAT) labeling of motor
neuron cell bodies in the ventral horn of the lumbar spinal cord in
6 and 24 month old Cra1/+ and +/+ mice demonstrates no
observable difference in motor neuron morphology or ChAT
expression in Cra1/+ mice (Figure 2A). Quantification of ChAT
labeled motor neurons reveals no difference in neuronal number
between Cra1/+ and +/+ mice (Figure 2B). The overall
appearance and number of anterior horn motor neurons is also
normal in 6 and 24 month old Cra1/+ mice as observed by
standard histochemistry with toluidine blue (Figure 2C, 2D). As 6
months is long after the emergence of abnormal hindlimb posture
(15 days of age) and impairments in hindlimb grip strength (3
months of age), this result indicates that the observed neuronal
dysfunction is not a result of motor neuron cell body loss.
Recent studies suggested that neurologic deficits in Cra1/+ and
Loa/+ mice are instead due to loss of proprioceptive sensory
neurons [11,12], a defect that would also result in the observed
phenotypes of hindlimb cramping and reduced grip strength [14].
Using several markers for DRG proprioceptive neurons, including
parvalbumin, ER81, and TrkC [15,16], we observe no difference
in proprioceptive neuron morphology or number between Cra1/+
and +/+ mice at 6 months of age (Figure 3A, 3B, 3C, respectively).
Additionally, we examined the connection between proprioceptive
afferents and primary motor neurons within the spinal cord.
Labeling of these fibers in the spinal cord with parvalbumin
revealed that proprioceptive fibers innervate motor neurons in the
spinal cord to a similar extent in both Cra1/+ and +/+ mice
(Figure 3D). Thus, proprioceptive neuron cell bodies, as well as
their central projections, are intact in symptomatic Cra1/+ mice.
Cra1/+ Mice Exhibit Reduced Complexity of
Neuromuscular Junctions
Although motor neuron cell bodies appear to be spared in
symptomatic Cra1/+ animals, synaptic dysfunction at the neuro-
muscular junction (NMJ) could potentially underlie the observed
behavioral abnormalities. This possibility would be consistent with
genetic data from Caenorhabditis elegans and Drosophila melanogaster,
where mutations in dynein components cause defects in synapse
assembly [17–20].Therefore,we examined neuromuscular junction
synapsesin2 month and 6 month oldCra1/+ and+/+ miceusinga-
bungarotoxin labeling of the tibialis anterior muscle (Figure 4A). In
Cra1/+ mice, there is no reduction in the number of NMJs
(Figure 4B). We examined the ‘‘total area’’ of each NMJ, defined by
the area contained within a boundary encompassing the outermost
edges of the NMJ, as revealed by a-bungarotoxin label (Figure 4Ai).
ThereisnodifferenceinNMJ totalareabetween Cra1/+and+/+at
2 months and 6 months of age (Figure 4C). However, because of the
complex, pretzel-like structure of the NMJ, total area contained
within the outside boundary does not accurately reflect the
‘‘synaptic area’’ of pre- and post-synaptic alignment where
intercellular communication occurs. Therefore, we also assessed
the synaptic area by quantifying the area within each NMJ that is
labeled by a-bungarotoxin (Figure 4Aii). The synaptic area within
eachNMJ is significantly reduced in Cra1/+ miceat 2 and 6 months
of age (Figure 4D) suggesting a reduction in complexity of the post-
synaptic component. To assess the presynaptic zone of the NMJ
synapse,weimagedmotorneuronaxons astheyinnervatetheNMJ,
using mice expressing GFP under the control of the HB9, motor
neuron-specific promoter [21]. When we costained the NMJs with
a-bungarotoxin and anti-GFP (Figure 5A), we found that there is
decreased innervation of NMJs in Cra1/+ mice (Figure 5B). Similar
results were seen when we co-stained with a-bungarotoxin and
neurofilament to visualize presynaptic motor neurons. Notably,
quantitative analysis of presynaptic innervation of NMJs revealed
NMJ Defects in Cra1/+ Mice
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overlap of the presynaptic axon and the post-synaptic acetylcholine
(ACh) receptors detected by a-bungarotoxin stain. Instead, the
proportion of NMJs that exhibit partial overlap between the
presynaptic axon and the post-synaptic ACh receptors is increased
in mutant animals. Such partial overlap has also been observed in
mouse models of spinal muscular atrophy [22], and suggests that
there is instability of the presynaptic components of the NMJ.
Together these data provide evidence of defects in both the pre and
post-synaptic components of the mutant NMJs.
During adult life, muscle fibers can degenerate and be replaced
by new muscle fibers; higher rates of muscle fiber turnover are
seen in response to nerve degeneration or to NMJ dysfunction. As
centrally localized nuclei mark the presence of regenerating muscle
fibers [23,21] we quantified centrally localized nuclei in the tibialis
anterior muscles of 6 month old Cra1/+ and +/+ mice. Figure 5C
demonstrates that there are more muscle fibers with central nuclei
in Cra1/+ animals, indicating increased muscle turnover. Such
changes in muscle fiber could be a consequence of NMJ
dysfunction, or might be a very early indicator of motor neuron
axon degeneration and regeneration.
The results presented here suggest a novel mechanism to
explain the behavioral abnormalities found in Cra1/+ mice. We
find evidence of an early-onset, stable phenotype of hindlimb
cramping and reduced grip strength. At symptomatic ages, we find
reduced morphological complexity in the neuromuscular junction.
This pathology occurs in the absence of either motor or sensory
neuron loss, suggesting that a developmental synaptic dysfunction
rather than an adult onset neurodegenerative syndrome underlies
the behavioral deficits in Cra1/+ mice.
Discussion
Previous reports on mice with hypomorphic mutations in dynein,
the Cra1/+, Loa/+ or Swl/+ mice, described a late-onset
degeneration of motor neurons, with progressive decline in motor
Figure 1. Cra1/+ mice show early-onset, non-progressive cramping of hindlimbs and reduced grip strength in fore- and hindlimbs.
A) Kaplan-Meier survival curves show a significant difference in survival between +/+ and Cra1/+ mice (*P,0.05). Cause of death is unknown, but
there was no evidence of nervous system dysfunction. B) Analysis of the ‘‘cramping’’ posture of +/+ and Cra1/+ mice. Quantification of average
cramping scores for +/+ and Cra1/+ mice from 15 days old through 12 months old shows an early onset, stable phenotype of increased cramping
posture in the Cra1/+ mice (N=17–34 +/+; N=19–36 Cra1/+). C) Grip strength measurements for both fore- and hindlimb show significant
impairments in grip strength for Cra1/+ mice beginning at early ages. Grip strength in Cra1/+ animals does not decline over time (*P,0.05;
comparisons between +/+ and Cra1/+ mice were calculated at 3 month intervals; N=5–34 +/+; N=5–31 Cra1/+).
doi:10.1371/journal.pone.0016753.g001
NMJ Defects in Cra1/+ Mice
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proprioceptive sensory neurons. Our recurrent behavioral assess-
ment of Cra1/+ mice shows an early onset, stable phenotype of
hindlimb cramping and impaired grip strength, with no further
progression in adulthood over the 24 months of testing. We
examined the anatomical underpinnings of this behavior. We find
no loss of either motor or sensory neurons at symptomatic ages;
instead, our analysis identifies decreased complexity of neuromus-
cular junction synapses, with associated muscle fiber abnormalities.
Dynein and its associated dynactin complex have been shown to
be important for synapse formation and stabilization in both
Drosophila and C. elegans [17,11,19,20]. In C. elegans, mutations in
genes encoding components of the dynein motor, including dynein
heavy chain, results in abnormal assembly of synapses. Addition-
ally, these mutants exhibit intracellular protein aggregations and
behavioral abnormalities including locomotor impairment, and
shorter lifespan [19]. Drosophila with mutations in genes encoding
components of the dynein/dynactin complex, as well as those with
mutations in dynein light chain genes, exhibit defects in synapses
of sensory and motor neurons [17–20]. These studies indicate that
dynein functions in the presynaptic terminal to promote synapse
stabilization and prevent synapse elimination [18].
Our findings of abnormal NMJ complexity in Cra1/+ mice
suggests that dynein plays a role in development and maintenance
of mammalian synapses as well. The morphological changes in
NMJ synapses and the associated alterations in muscle fibers, as
well as the early onset of behavioral deficits in Cra1/+ mice,
suggest that synapse formation, stability and refinement are altered
by defects in dynein function. Thus, the Cra1/+ mice provide a
useful model to examine the role of dynein in the dynamic
processes of NMJ synapse formation and stabilization.
It is currently unclear why there are such large discrepancies in
the phenotypes of the Cra1/+ and Loa/+ mice as described by
different groups. Clearly these mutations in the dynein heavy
chain gene affect the lower motor neuron circuitry comprising the
primary motor neurons, the innervated muscle and the proprio-
ceptive neurons that innervate the muscles. It is apparent that
deterioration in a particular portion of this circuitry can ultimately
result in dysfunction of the entire circuit. However, it has not been
clear where or how dynein mutations initiate abnormalities in this
circuit.
Our behavioral analysis reveals that the mice exhibit deficits
from an early age, while anatomical analysis indicates that
disruption of NMJ synaptic structure is present and precedes
any motor or sensory neuron loss. We did not observe any
evidence of late degeneration; however, it is possible that early
disruption in synaptic function at the NMJ could prime motor
neuron or sensory neuron cell bodies for later degeneration under
some conditions [11,9,12]. Thus, it may be important to consider
the effect of environment on the manifestation of phenotypes in
Figure 2. Cra1/+ mice show no evidence of motor neuron loss at symptomatic ages. A) Motor neuron labeling with ChAT of +/+ and Cra1/+
mice at 6 months and 24 months of age (Scale bar =50 mm). B) Quantification of ChAT-labeled motor neurons reveals no difference in number
between +/+ and Cra1/+ mice (N=3 animals per genotype). C) Toluidine blue staining of the anterior horn of the spinal cord at 6 months and 24
months of age in +/+ and Cra1/+ mice (white arrows indicate motor neurons, Scale bar =50 mm). D) Quantification of toluidine blue labeled motor
neurons reveals no difference in number between +/+ and Cra1/+ mice (N=3 animals per genotype).
doi:10.1371/journal.pone.0016753.g002
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intake can dramatically affect age-related changes in neuromus-
cular junctions in mice [24]. Since we find that one of the primary
sites of dysfunction in Cra1/+ mice is at the NMJ, variations
among laboratories in housing conditions and daily food intake
will impact the emergence of this phenotype and may account for
some of the divergent reports of phenotypes.
Intriguingly, a recent study by Braunstein et al. finds striatal
atrophy, abnormal dopamine signaling, and impaired neurite
outgrowth of striatal neurons in Cra1/+ mice. These data
suggest that under some conditions dynein mutations may affect
multiple circuits in the central asw e l la st h ep e r i p h e r a ln e r v o u s
system [25].
In conclusion, we provide evidence for an early-onset, stable
phenotype in Cra1/+ mice. In contrast to previous reports, we find
no evidence of either motor or sensory neuron loss at symptomatic
ages. Instead, we find evidence of altered topology of NMJs, in that
the area within each synapse that is covered by acetylcholine
receptors is reduced, together with a reduction in the region of
overlap with the presynaptic axon terminal. We propose that
disruption of dynein function in Cra1/+ mice results in
abnormalities of neuromuscular junction synapse formation,
refinement, and/or stabilization. Therefore, Cra1/+ mice may
prove to be a useful tool to examine the process of synaptogenesis
and maturation at the mammalian NMJ.
Materials and Methods
Animal Use
Cra1/+ mice were purchased under an MTA agreement from
Ingenium Pharmaceuticals. Genotyping for the Cra1 point mutation
was performed by Transnetyx, Inc. (Cordova, TN) using a wild type
or Cra1 targeting sequence (TGTGTTTCCTTTGCAGGTTTG-
GCTTCAGT[A/G]CCAGTGTTTGTGGGATATGCAGGCA-
GAAAACATTTACAACAGGCTAGGGGAA). HB9-GFP mice
[21] were obtained from Jackson Laboratory. To obtain Cra1/+
mice expressing GFP in motor neurons, HB9-GFP heterozygous
mice(HB9-GFP/+) werecrossed withCra1/+ miceto obtain Cra1/+
HB9-GFP/+ mice. Only doubly-heterozygous offspring from the
original Cra1/+ and HB9-GFP/+ cross were used. All experimental
procedures were done in accordance with the National Institutes of
Health guidelines and were approved by the Dana-Farber Cancer
Institutional Animal Care and Use Committee. The permit number
is 03-054.
Behavior Analyses
Kaplan-Meier survival curves were generated using Prism
statistical software, and analyzed using the Curve Comparison
analysis for survival data.
Cramping behavior was measured by lifting the animal gently
by the tail, suspending the hindlimbs and leaving forelimbs
touching the ground. Two independent observers scored the
animal as 1 (no hindlimb abnormalities), 2 (cramping of
hindlimbs), or 3 (paralysis of one or both hindlimbs). Scorers
were blind to genotype.
Grip strength was measured using a digital grip strength meter,
which records the maximal strength an animal exerts while trying
to resist an opposing pulling force (Columbus Instruments,
Columbus, OH). Forelimb grip strength was measured using a
mouse tension bar, and hindlimb grip strength was measured using
a mouse compression bar. The results of three consecutive trials on
the same day were averaged for each animal. Significance was
calculated by Student’s two-tailed t-test. Statistical tests were
performed at every third time point (3 months, 6 months, etc.).
Testers were blind to genotype.
Motor Neuron Labeling
Cra1/+ and +/+ mice were euthanized and perfused with PBS,
followed by 4% paraformaldehyde (PFA). The lumbar enlarge-
ment of the spinal cord was removed, post-fixed in 4% PFA
overnight at 4uC, then cryopreserved in 30% sucrose at 4uC
overnight. Spinal cords were frozen at 220uC, and sliced at
14 mm. For ChAT staining, slices were blocked in 10% normal
donkey serum and 0.1% TritonX-100 in PBS for 1 hour at room
temperature, then incubated in goat anti-choline acetyltransferase
(ChAT) antibody (1:100, Chemicon, Cat# AB144P) overnight at
4uC. Tissue was then incubated in biotinlyated donkey anti-goat
antibody (1:300, Vector Laboratory), followed by streptavidin
conjugated Alexa 546 (1:500, Invitrogen), then counterstained
with DAPI (1:1000) for 1 minute. Images were obtained with a
40X oil objective using NIS Elements software. ChAT labeled
motor neurons were quantified by counting neurons containing a
nuclear profile; 8 sections of the spinal cord anterior horn per
animal, from three sets (Cra1/+ and +/+) of animals at each age
were analyzed. For toluidine blue staining, slices were dried on a
hot plate and a drop of filtered toluidine blue solution (1%
toluidine blue O (basic blue 17), 1% sodium borate) was added to
the slide and then rinsed in water when the solution began to dry.
Images were obtained with a 10X objective using NIS Elements
software. Toluidine blue labeled motor neurons were quantified by
counting only neurons greater than or equal to 600 mm
2 in size; 8
sections of the spinal cord anterior horn per animal, from three
pairs (one Cra1/+ and one +/+) of animals at each age were
analyzed.
Sensory Neuron Labeling
Cra1/+ and +/+ mice were euthanized and perfused with PBS,
followed by 4% PFA. L4 and L5 dorsal root ganglia (DRG) were
removed, post-fixed in 4% PFA overnight at 4uC, then crysostat
sections along the longitudinal plane of the ganglia were prepared
as described above. For parvalbumin and ER81 labeling, sections
were blocked in 10% normal goat serum and 0.1% TritonX-100
in PBS for 1 hour at room temperature, then incubated in rabbit
anti-parvalbumin (Abcam, 1:200, Cat# ab45542) or rabbit anti-
ER81 (Abcam, 1:1000, Cat# ab36788) overnight at 4uC. Tissue
was then incubated in goat anti-rabbit Alexa-546 (Molecular
Probes, 1:1000) for 1 hour at room temperature, and then
counterstained with DAPI. For TrkC staining, sections were
blocked in 10% normal horse serum and 0.1% TritonX-100 in
PBS for 1 hour at room temperature, then incubated in goat anti-
TrkC (R&D Systems, 1:100, Cat# AF1404) overnight at 4uC.
Tissue was then incubated in horse anti-goat Alexa-546 (Molec-
ular Probes, 1:1000) for 1 hour at room temperature, and then
counterstained with DAPI.
Proprioceptive sensory neurons were quantified by counting 8
sections per animal, from three sets (Cra1/+ and +/+) of animals.
Figure 3. Cra1/+ mice show no evidence of proprioceptive sensory neuron loss at symptomatic ages. A) Proprioceptive sensory neuron
labeling and quantification with parvalbumin, (B) ER81, and (C) TrkC shows no difference between of +/+ and Cra1/+ mice at 6 months of age (Scale
bar =20 mm). D) Parvalbumin labeling of proprioceptive sensory neuron fibers within the spinal cord shows the central projection of these sensory
neurons is intact in Cra1/+ mice (Scale bar =20 mm; N=3 animals per genotype).
doi:10.1371/journal.pone.0016753.g003
NMJ Defects in Cra1/+ Mice
PLoS ONE | www.plosone.org 6 February 2011 | Volume 6 | Issue 2 | e16753Figure 4. Neuromuscular junctions of Cra1/+ mice are abnormal at symptomatic ages. A) a-bungarotoxin labeled NMJs (Scale bar
=20mm) B) Quantification of a-bungarotoxin labeling demonstrates no differences in the number of NMJs per section (N=3 animals per genotype).
C) Quantification of a-bungarotoxin labeled NMJs demonstrates no difference in total area (as measured by delineating outer edge and measuring
area within that boundary, area analyzed is within white trace of 4Ai) of NMJs in Cra1/+ mice (N=3 animals per genotype). D) NMJ complexity, as
measured by the synaptic area of a-bungarotoxin label (4Aii), is significantly decreased in 2 month and 6 month old Cra1/+ mice (*P,0.05; N=3 mice
per genotype).
doi:10.1371/journal.pone.0016753.g004
NMJ Defects in Cra1/+ Mice
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compared to the total number of nuclei in the section to calculate
the percentage of sensory neurons that are proprioceptors.
For labeling of proprioceptive fibers within the spinal cord,
Cra1/+ and +/+ mice were euthanized and perfused with PBS,
followed by 4% PFA, and sections of the lumbar enlargement of
the spinal cord were prepared as described above. Sections were
blocked in 10% normal goat serum and 0.1% TritonX-100 in PBS
for 1 hour at room temperature, then incubated in rabbit anti-
parvalbumin (Swant, 1:1000, Cat# PV-28) overnight at 4uC.
Tissue was then incubated in goat anti-rabbit Alexa-546
(Molecular Probes, 1:1000) for 1 hour at room temperature, and
then counterstained with DAPI. Three pairs (one Cra1/+ and one
+/+) of animals were examined.
Neuromuscular Junction Labeling
Cra1/+ and +/+ mice were euthanized and perfused with PBS,
followed by 4% PFA. The tibialis anterior muscle was removed,
post-fixed in 4% PFA overnight at 4uC, then cryopreserved in
30% sucrose at 4uC overnight. Muscles were frozen at 220uC,
and sliced longitudinally at 40 mm. Muscle tissue was blocked in
3% bovine serum albumin, 2.5% normal goat serum, and 0.1%
TritonX-100 in PBS for 1 hour at room temperature, then
incubated in a-bungarotoxin-tetramethylrhodamine (1:500, Mo-
lecular Probes, Cat# T1175) overnight at 4uC, then counter-
stained with DAPI. Confocal images were obtained using a Zeiss
LSM 510 META upright confocal microscope, using a 40X air
objective.
Measurements of overall NMJ area were determined by
delineating the outside edge of the a-bungarotoxin labeled NMJ,
then measuring the total area within that outline. For each
synapse, measurements of complexity were obtained by measuring
the area of fluorescent signal that is above background and is
within the outline of the NMJ. NMJ analysis was done using
Metamorph software by counting 8 sections of the tibialis anterior
muscle per animal from three pairs (one Cra1/+ and one +/+)o f
animals at each age.
Muscle Fiber Labeling
Cryostat sections of the tibialis anterior muscle from Cra1/+ and
+/+ mice were prepared and stained as above. Centrally localized
nuclei were counted and compared to the total number of nuclei in
the section to calculate the percentage regenerating muscle fibers.
Quantification was done by using 8 sections of the tibialis anterior
muscle per animal from three pairs (one Cra1/+ and one +/+)o f
animals.
Figure 5. Synaptic and post-synaptic defects at the neuromuscular junctions in Cra1/+ mice. A) a-bungarotoxin and GFP labeled NMJs.
(Scale bar =20 mm). B) Motor neuron axons reveal a decrease in the proportion of NMJs with complete overlap between pre and post-synaptic zones
and a compensatory increase in the proportion of NMJs with partial overlap in Cra1/+ mice (*P,0.05). C) Labeling of nuclei by DAPI stain
demonstrates a significant increase in central nuclei in Cra1/+ mice, a measure of muscle fiber degeneration and regeneration (central nuclei
indicated with red arrow; *P,0.05; N=3 mice per genotype).
doi:10.1371/journal.pone.0016753.g005
NMJ Defects in Cra1/+ Mice
PLoS ONE | www.plosone.org 8 February 2011 | Volume 6 | Issue 2 | e16753Acknowledgments
We thank Jennifer Kalscheuer for technical assistance. We thank Joshua
Sanes, Katharina Cosker and Sara Fenstermacher for helpful comments.
Author Contributions
Conceived and designed the experiments: SLC MFP-M RAS. Performed
the experiments: SLC MFP-M DJL. Analyzed the data: SLC MFP-M DJL.
Contributed reagents/materials/analysis tools: SLC MFP-M DJL. Wrote
the paper: SLC RAS.
References
1. Cosker KE, Courchesne SL, Segal RA (2008) Action in the axon: generation and
transport of signaling endosomes. Curr Opin Neurobiol 18: 270–275.
2. De Vos KJ, Grierson AJ, Ackerley S, Miller CC (2008) Role of axonal transport
in neurodegenerative diseases. Annu Rev Neurosci 31: 151–173.
3. Holzbaur EL (2004) Motor neurons rely on motor proteins. Trends Cell Biol 14:
233–240.
4. Salinas S, Bilsland LG, Schiavo G (2008) Molecular landmarks along the axonal
route: axonal transport in health and disease. Curr Opin Cell Biol 20: 445–453.
5. LaMonte BH, Wallace KE, Holloway BA, Shelly SS, Ascano J, et al. (2002)
Disruption of dynein/dynactin inhibits axonal transport in motor neurons
causing late-onset progressive degeneration. Neuron 34: 715–727.
6. Puls I, Jonnakuty C, LaMonte BH, Holzbaur EL, Tokito M, et al. (2003) Mutant
dynactin in motor neuron disease. Nat Genet 33: 455–456.
7. Chevalier-Larsen ES, Wallace KE, Pennise CR, Holzbaur EL (2008) Lysosomal
proliferation and distal degeneration in motor neurons expressing the G59S
mutation in the p150Glued subunit of dynactin. Hum Mol Genet 17:
1946–1955.
8. Laird FM, Farah MH, Ackerley S, Hoke A, Maragakis N, et al. (2008) Motor
neuron disease occurring in a mutant dynactin mouse model is characterized by
defects in vesicular trafficking. J Neurosci 28: 1997–2005.
9. Hafezparast M, Klocke R, Ruhrberg C, Marquardt A, Ahmad-Annuar A, et al.
(2003) Mutations in dynein link motor neuron degeneration to defects in
retrograde transport. Science 300: 808–812.
10. Ori-McKenney KM, Xu J, Gross SP, Vallee RB (2010) A cytoplasmic dynein
tail mutation impairs motor processivity. Nat Cell Biol 12: 1123–1249.
11. Dupuis L, Fergani A, Braunstein KE, Eschbach J, Holl N, et al. (2009) Mice with
a mutation in the dynein heavy chain 1 gene display sensory neuropathy but lack
motor neuron disease. Exp Neurol 215: 146–152.
12. Ilieva HS, Yamanaka K, Malkmus S, Kakinohana O, Yaksh T, et al. (2008)
Mutant dynein (Loa) triggers proprioceptive axon loss that extends survival only
in the SOD1 ALS model with highest motor neuron death. Proc Natl Acad
Sci U S A 105: 12599–12604.
13. Chen XJ, Levedakou EN, Millen KJ, Wollmann RL, Soliven B, et al. (2007)
Proprioceptive sensory neuropathy in mice with a mutation in the cytoplasmic
dynein heavy chain 1 gene. J Neurosci 27: 14515–14524.
14. Fowler SC, Zarcone TJ, Chen R, Taylor MD, Wright DE (2002) Low grip
strength, impaired tongue force and hyperactivity induced by overexpression of
neurotrophin-3 in mouse skeletal muscle. Int J Dev Neurosci 20: 303–308.
15. Oakley RA, Lefcort FB, Clary DO, Reichardt LF, Prevette D, et al. (1997)
Neurotrophin-3 promotes the differentiation of muscle spindle afferents in the
absence of peripheral targets. J Neurosci 17: 4262–4274.
16. Patel TD, Kramer I, Kucera J, Niederkofler V, Jessell TM, et al. (2003)
Peripheral NT3 signaling is required for ETS protein expression and central
patterning of proprioceptive sensory afferents. Neuron 38: 403–416.
17. Allen MJ, Shan X, Caruccio P, Froggett SJ, Moffat KG, et al. (1999) Targeted
expression of truncated glued disrupts giant fiber synapse formation in
Drosophila. J Neurosci 19: 9374–9384.
18. Eaton BA, Fetter RD, Davis GW (2002) Dynactin is necessary for synapse
stabilization. Neuron 34: 729–741.
19. Koushika SP, Schaefer AM, Vincent R, Willis JH, Bowerman B, et al. (2004)
Mutations in Caenorhabditis elegans cytoplasmic dynein components reveal
specificity of neuronal retrograde cargo. J Neurosci 24: 3907–3916.
20. Murphey RK, Caruccio PC, Getzinger M, Westgate PJ, Phillis RW (1999)
Dynein-dynactin function and sensory axon growth during Drosophila
metamorphosis: A role for retrograde motors. Dev Biol 209: 86–97.
21. Wichterle H, Lieberam I, Porter JA, Jessell TM (2002) Directed differentiation of
embryonic stem cells into motor neurons. Cell 110: 385–397.
22. Cifuentes-Diaz C, Nicole S, Velasco ME, Borra-Cebrian C, Panozzo C, et al.
(2002) Neurofilament accumulation at the motor endplate and lack of axonal
sprouting in a spinal muscular atrophy mouse model. Hum Mol Genet 11:
1439–1447.
23. Schmalbruch H (1976) The morphology of regeneration of skeletal muscles in
the rat. Tissue Cell 8: 673–692.
24. Valdez G, Tapia JC, Kang H, Clemenson Jr. GD, Gage FH, et al. (2010)
Attenuation of age-related changes in mouse neuromuscular synapses by caloric
restriction and exercise. Proc Natl Acad Sci U S A 107: 14863–14868.
25. Braunstein KE, Eschbach J, Ro `na-Vo ¨ro ¨s K, Soylu R, Mikrouli E, et al. (2010) A
point mutation in the dynein heavy chain gene leads to striatal atrophy and
compromises neurite outgrowth of striatal neurons. Hum Mol Genet 19(22):
4385–4398.
NMJ Defects in Cra1/+ Mice
PLoS ONE | www.plosone.org 9 February 2011 | Volume 6 | Issue 2 | e16753